Cellective BioTherapy, Inc. (CBT) is a biotechnology company founded in 2015 that is developing antibody and cell-based approaches to harnessing regulatory B (B10) cells for both augmenting a patient's immunity against tumors and for the production of personalized cellular therapies to treat diverse and complex inflammatory disorders and autoimmune disease.

Biotechnology

Cellective BioTherapy

Thomas F. Tedder

Robert Bonczek

Bud Nelson

Cellective BioTherapy's Leadership Team includes Thomas F. Tedder and 2 others.

Leadership Team

About

Team members